Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01061944 · ClinicalTrials.gov registry record
Biopsies of Cancer Patients for Tumor Molecular Characterization
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 188
- Enrollment target
NCT01061944: Completed study, sponsored by Massachusetts General Hospital.
NCT01061944 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01061944 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
In this research study, we are looking at performing a repeat biopsy of patients' tumors, even though they have already been diagnosed with cancer. The tumor tissue obtained from the biopsy will be studied to see what it looks like at the molecular (genetic) level. By conducting this study, we hope to learn more about how cancers work, why cancers respond to certain treatments, and how they become resistant to certain treatments. We also hope to demonstrate that biopsies like this can be performed safely in large numbers of patients. The research done on the tumor samples may help us identify which patients in the future are most likely to respond to new cancer therapies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2010-02 |
| Est. Completion | 2018-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01061944
The ClinicalTrials.gov registry entry for NCT01061944 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 188 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01061944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01061944 about?
NCT01061944 is a clinical study titled "Biopsies of Cancer Patients for Tumor Molecular Characterization". In this research study, we are looking at performing a repeat biopsy of patients' tumors, even though they have already been diagnosed with cancer. The tumor tissue obtained from the biopsy will be studied to see what it looks like at the molecular (genetic) level. By conducting this study, we hope ...
What is the current status of trial NCT01061944?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2010-02. Estimated completion is 2018-01.
Who is sponsoring clinical trial NCT01061944?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.